Reported Earlier: U.S. FDA Grants Tentative Approval For Dr. Reddy’s Twice-Yearly Injectable Lenacapavir, Advancing Access To HIV Prevention Across 120 Countries Outside The U.S.
https://www.drreddys.com/cms/sites/default/files/2026-11/20261102_Lenacapavir_Generic_FDA_Approval_PressRelease_Final.pdf
Share
Why It Matters
Dr. Reddy's got approval to make a cheaper HIV prevention shot. This could help millions of people in over 100 countries get medicine they need.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.